Universe Pharmaceuticals (UPC) Long-Term Investments (2020 - 2025)

Universe Pharmaceuticals (UPC) has 6 years of Long-Term Investments data on file, last reported at $702.3 million in Q3 2025.

• For the quarter ending Q3 2025, Long-Term Investments fell 1.42% year-over-year to $702.3 million; the trailing twelve-month figure through Sep 2025 stood at $702.3 million (down 1.42% YoY), and the FY2025 full-year result was $702.3 million, down 1.42% from the prior year.
• Long-Term Investments declined to $702.3 million in Q3 2025, from $712.5 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $712.5 million in Q3 2024 to a low of $586674.0 in Q1 2022.
• A 5-year average of $265.1 million and a median of $736489.5 in 2021 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments tumbled 100.0% in 2021 and jumped 99822.61% in 2023, its largest moves.
• Tracing UPC's Long-Term Investments over 5 years: stood at $744924.0 in 2021, then decreased by 5.64% to $702890.0 in 2022, then jumped by 99822.61% to $702.3 million in 2023, then grew by 1.44% to $712.5 million in 2024, then dropped by 1.42% to $702.3 million in 2025.
• Business Quant data shows UPC's Long-Term Investments at $702.3 million in Q3 2025, $712.5 million in Q3 2024, and $692492.0 in Q1 2024.